谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Neoadjuvant Talazoparib in Patients with Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Exploration of Tumor BRCA Mutational Status.

Melinda L. Telli,Jennifer K. Litton,J. Thaddeus Beck,Jason M. Jones,Jay Andersen,Lida A. Mina,Raymond Brig,Michael Danso, Yuan,William F. Symmans,Julia F. Hopkins,Lee A. Albacker,Antonello Abbattista,Kay Noonan,Marielena Mata,A. Douglas Laird,Joanne L. Blum

BREAST CANCER（2024）

引用 0|浏览19
暂无评分
关键词
Talazoparib,Neoadjuvant,BRCA1,BRCA2,Triple-negative breast cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要